½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1611815

¼¼°èÀÇ ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå : Á¦Ç° À¯Çü, ÆäÀÌÁî, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Surgical Site Infection Control Market by Product (Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Clippers), Type (Deep Incisional Infection, Space Infection, Superficial Incisional Infection), Phase, End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀº 2023³â¿¡ 52¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 56¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6.34%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 81¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå¿¡´Â ¼ö¼ú Àý°³ ºÎÀ§¿¡¼­ ¹ß»ýÇÏ´Â °¨¿°ÀÇ ¿¹¹æ, Áø´Ü ¹× Ä¡·á¿¡ ÁßÁ¡À» µÐ ´Ù¾çÇÑ ¹æ¹ý°ú Á¦Ç°ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÔ¿ø ±â°£À» ´ÜÃàÇÏ°í ÀÇ·áºñ¸¦ Àý°¨ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ¼¼°èÀÇ °Ç°­ °ü¸® ½Ã¼³¿¡ Çʼö ºÒ°¡°áÇÑ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù.º´¿ø, ¿Ü·¡ Áø·á¼Ò, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿¡¼­ »ç¿ëµÇ¾î ÁÖ¼ú±â ÀÇ·á¿Í °¨¿° °ü¸®ÀÇ °­È­¸¦ ¸ñÇ¥·Î ÇÏ°í ÀÖ½À´Ï´Ù. »ç·Ê¸¦ ½Ç½ÃÇÏ´Â µ¥ ÁßÁ¡À» µÐ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, º´¿ø ¹× Á¶»ç ±â°üÀÌ Æ÷ÇԵ˴ϴÙ.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 52¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 56¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 81¾ï 4,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 6.34%

ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¼ö¼ú °Ç¼ö Áõ°¡, SSI ÇÕº´Áõ¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾ÆÁü, º¸´Ù °ß°íÇÑ °¨¿° ´ëÃ¥ÀÌ ÇÊ¿äÇÑ ¼ö¼ú ¼ö¼úÀÇ Áøº¸, Á¾ÇÕÀûÀÎ °¨¿° ´ëÃ¥ ÇÁ·ÎÅäÄÝÀ» Àǹ«È­ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç×±Õ ºÀÇÕ»ç, »óó ¼¼Ã´ ÀåÄ¡, °í±Þ ¸ê±Õ ¹æ¹ýÀÇ Çõ½Åµµ ¼ºÀå ±âȸ¸¦ °¡Á®¿É´Ï´Ù. ÈçÀû°ú °ü¸®¿¡¼­ AI¿Í µ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕÀº ¹Ì°³Ã´ °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù. ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÔ°ú µ¿½Ã¿¡ AIÀÇ Áøº¸¸¦ È°¿ëÇϱâ À§ÇÑ ±â¼ú±â¾÷°úÀÇ Á¦ÈÞ¸¦ ¸ð»öÇØ¾ß ÇÕ´Ï´Ù.

±×·¯³ª °í±Þ °¨¿° Á¦¾î Á¦Ç°ÀÇ °íºñ¿ë, ÀüÅëÀûÀÎ ¹æ¹ýÀ» ½Å·ÚÇÏ´Â »ç¶÷µéÀÇ ÀúÇ×, ƯÁ¤ ¿¹¹æ ¼ö´Ü°ú °ü·ÃµÈ ÀáÀçÀû ºÎÀÛ¿ë µî ½ÃÀå ¼ºÀåÀº ¸î °¡Áö °úÁ¦¿¡ Á÷¸é ÇØ ÀÖ½À´Ï´Ù. À庮°ú ¼¼°èÀû ¿¡ ÀÏ°ü¼º ¾ø´Â ½ÃÇàÀº ÀÌ·¯ÇÑ ¹®Á¦¸¦ ´õ¿í º¹ÀâÇÏ°Ô ÇÕ´Ï´Ù. ¼ö¼úºÎ À§Ä¡¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇϱâ À§ÇÑ ¿þ¾î·¯ºí ±â¼úÀÇ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù. ÇÕÃÄ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ Áö¿ª ½ÃÀåÀÇ ´µ¾Ó½º¸¦ ÀÌÇØÇÏ°í Áö¿ª ƯÀ¯ÀÇ ¿ä±¸¿¡ ¸Â°Ô ¼Ö·ç¼ÇÀ» Àû¿ëÇÏ´Â °Íµµ »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆľÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿ø³» °¨¿° Áõ°¡
    • ¸¸¼ºÁúȯÀÇ À¯Çà°ú ¼ö¼ú ¿É¼Ç Áõ°¡
    • º´¿øÀÇ ÀÎÇÁ¶ó Á¤ºñ¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ö¼ú ºÎÀ§ °¨¿°ÀÇ Æ¯Á¤ÀÌ °ï¶õ
  • ½ÃÀå ±âȸ
    • ¼ö¼ú ºÎÀ§ÀÇ °¨¿° Á¦¾î¿¡ À־ÀÇ ±â¼úÀÇ Áøº¸
    • ¼ö¼ú ºÎÀ§ °¨¿° ±ÙÀýÀ» À§ÇÑ ¹ÙÀÌ¿À Çʸ§
  • ½ÃÀåÀÇ °úÁ¦
    • ¼ö¼ú ¼ö¼ú¿¡ °üÇÑ Ç¥ÁØ ±Ô¹üÀÇ ½Ç½Ã¿¡ ´ëÇÑ ¼Ò±Ø¼º

Porter's Five Forces : ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡ÇÏ°í Àü·«Àû ±âȸ¸¦ Ž±¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» È°¿ëÇÏ°í, ¾àÁ¡À» ÇØ°áÇÏ°í, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆľÇ

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆľÇ

¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®ÇÏ°í Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù..

Àü·« ºÐ¼® ¹× Ãßõ ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D È°µ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¿ø³» °¨¿° Áõ°¡
      • ¸¸¼º ÁúȯÀÇ ¸¸¿¬°ú ¼ö¼ú ¼±Åà Áõ°¡
      • º´¿ø ÀÎÇÁ¶óÀÇ ¹ßÀü¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø
    • ¾ïÁ¦¿äÀÎ
      • ¼ö¼ú ºÎÀ§ °¨¿°ÀÇ Æ¯Á¤ÀÌ °ï¶õ
    • ±âȸ
      • ¿Ü°úÀû °¨¿° Á¦¾î¿¡ À־ÀÇ ±â¼úÀû Áøº¸
      • ¼ö¼ú ºÎÀ§ °¨¿°À» ±ÙÀýÇϱâ À§ÇÑ ¹ÙÀÌ¿À Çʸ§
    • °úÁ¦
      • ¿Ü°ú ¼ö¼úÀÇ Ç¥ÁØ ±âÁØÀÇ ½Ç½Ã¿¡ ´ëÇÑ ¼Ò±ØÀû ŵµ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå : Á¦Ç°º°

  • Ç×»ýÁ¦ ¿¹¹æ Á¦Ç°
  • ¼Òµ¶Á¦
  • ¹Ù¸®Ä­
  • ¼ö¼ú¿ë µå·¹ÀÌÇÁ
  • »óó Äɾî¿ë µå·¹½Ì
  • »óó ¼¼Ã´ Á¦Ç°

Á¦7Àå ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå : À¯Çüº°

  • ½ÉºÎ Àý°³ºÎ °¨¿°
  • Àý°³ºÎ °¨¿°
  • ¾èÀº Àý°³ºÎ °¨¿°

Á¦8Àå ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå : ´Ü°èº°

  • ¼ö¼ú Áß ´Ü°è
  • ¼ö¼ú ÈÄ ´Ü°è
  • ¼ö¼ú Àü ´Ü°è

Á¦9Àå ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå

  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼ö¼ú ºÎÀ§ °¨¿° °ü¸® ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • Ansell Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Belimed AG
  • bioMerieux SA
  • Covalon Technologies Ltd.
  • Europe BV
  • Getinge Group
  • Johnson & Johnson Services, Inc.
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Prescient Surgical, Inc.
  • Steris Corporation
  • Stryker Corporation
  • Winner Medical Group Inc.
BJH 24.12.24

The Surgical Site Infection Control Market was valued at USD 5.29 billion in 2023, expected to reach USD 5.62 billion in 2024, and is projected to grow at a CAGR of 6.34%, to USD 8.14 billion by 2030.

The scope of the surgical site infection (SSI) control market encompasses various methods and products focused on the prevention, diagnosis, and treatment of infections occurring at the site of a surgical incision. SSI control is crucial to improving patient outcomes, reducing hospital stays, and lowering healthcare costs, making it a necessity for healthcare facilities globally. Applications are widespread, with use in hospitals, outpatient clinics, and ambulatory surgical centers aiming to enhance perioperative care and infection management. The market's end-use scope includes healthcare providers, hospitals, and research institutions focused on implementing best practices in infection prevention and control.

KEY MARKET STATISTICS
Base Year [2023] USD 5.29 billion
Estimated Year [2024] USD 5.62 billion
Forecast Year [2030] USD 8.14 billion
CAGR (%) 6.34%

Key growth factors include increasing surgery volumes, heightened awareness regarding SSI complications, advancements in surgical techniques necessitating more robust infection control measures, and stringent regulations mandating comprehensive infection control protocols. Innovations in antimicrobial sutures, wound cleaning devices, and advanced sterilization methods also present growth opportunities. Furthermore, the integration of AI and data analytics in infection tracking and management offers untapped potential. To capitalize on these opportunities, stakeholders should invest in R&D to develop more efficient and cost-effective SSI control solutions while exploring partnerships with technology firms to leverage AI advancements.

However, market growth faces several challenges, such as the high cost of advanced infection control products, resistance from traditional method adherents, and potential side effects associated with certain prevention measures. Regulatory barriers and inconsistent enforcement globally further compound these issues. Areas ripe for innovation include developing low-cost, high-efficacy antiseptics, portable sterilization units for remote or resource-poor settings, and wearable technology for real-time monitoring of surgical sites. To navigate this market successfully, businesses should focus on cross-disciplinary research collaborations and engage with regulatory bodies to align product development with the latest standards. Understanding regional market nuances and adapting solutions to meet specific local needs will also prove beneficial in capturing emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Surgical Site Infection Control Market

The Surgical Site Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in number of hospital-acquired infections
    • Prevalence of chronic disease and increasing surgery options
    • Government support for advancing hospital infrastructure
  • Market Restraints
    • Difficulty in identifying the surgical site infection
  • Market Opportunities
    • Technological advancements in surgical infection control
    • Biofilms for eradicating surgical site infections
  • Market Challenges
    • Reluctance for implementation of standard norms for surgical procedures

Porter's Five Forces: A Strategic Tool for Navigating the Surgical Site Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Surgical Site Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Surgical Site Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Surgical Site Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Surgical Site Infection Control Market

A detailed market share analysis in the Surgical Site Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Surgical Site Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Surgical Site Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Surgical Site Infection Control Market

A strategic analysis of the Surgical Site Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Surgical Site Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Ansell Ltd., B. Braun Melsungen AG, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Covalon Technologies Ltd., Europe BV, Getinge Group, Johnson & Johnson Services, Inc., Kimberly-Clark Corporation, Medtronic PLC, Molnlycke Health Care AB, Paul Hartmann AG, Prescient Surgical, Inc., Steris Corporation, Stryker Corporation, and Winner Medical Group Inc..

Market Segmentation & Coverage

This research report categorizes the Surgical Site Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Clippers, Surgical Drapes, Wound Care Dressings, and Wound Irrigation Products.
  • Based on Type, market is studied across Deep Incisional Infection, Space Infection, and Superficial Incisional Infection.
  • Based on Phase, market is studied across Intraoperative Phase, Postoperative Phase, and Preoperative Phase.
  • Based on End-user, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in number of hospital-acquired infections
      • 5.1.1.2. Prevalence of chronic disease and increasing surgery options
      • 5.1.1.3. Government support for advancing hospital infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulty in identifying the surgical site infection
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in surgical infection control
      • 5.1.3.2. Biofilms for eradicating surgical site infections
    • 5.1.4. Challenges
      • 5.1.4.1. Reluctance for implementation of standard norms for surgical procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Surgical Site Infection Control Market, by Product

  • 6.1. Introduction
  • 6.2. Antibiotic Prophylaxis Products
  • 6.3. Antiseptics & Disinfectants
  • 6.4. Clippers
  • 6.5. Surgical Drapes
  • 6.6. Wound Care Dressings
  • 6.7. Wound Irrigation Products

7. Surgical Site Infection Control Market, by Type

  • 7.1. Introduction
  • 7.2. Deep Incisional Infection
  • 7.3. Space Infection
  • 7.4. Superficial Incisional Infection

8. Surgical Site Infection Control Market, by Phase

  • 8.1. Introduction
  • 8.2. Intraoperative Phase
  • 8.3. Postoperative Phase
  • 8.4. Preoperative Phase

9. Surgical Site Infection Control Market, by End-user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics
  • 9.4. Hospitals

10. Americas Surgical Site Infection Control Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Surgical Site Infection Control Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Surgical Site Infection Control Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Ansell Ltd.
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. Belimed AG
  • 6. bioMerieux SA
  • 7. Covalon Technologies Ltd.
  • 8. Europe BV
  • 9. Getinge Group
  • 10. Johnson & Johnson Services, Inc.
  • 11. Kimberly-Clark Corporation
  • 12. Medtronic PLC
  • 13. Molnlycke Health Care AB
  • 14. Paul Hartmann AG
  • 15. Prescient Surgical, Inc.
  • 16. Steris Corporation
  • 17. Stryker Corporation
  • 18. Winner Medical Group Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦